| Abstract
| - 5,6-Dimethoxy-2-(N-dipropyl)-aminoindan (3, PNU-99194A) was found to be a selectivedopamine D3 receptor antagonist with potential antipsychotic properties in animal models. Toinvestigate the effects of nitrogen substitution on structure−activity relationships, a series of5,6-dimethoxy-N-alkyl- and N-alkylaryl-substituted 2-aminoindans were synthesized andevaluated in vitro for binding affinity and metabolic stability. The results indicate thatsubstitution at the amine nitrogen of the 2-aminoindans is fairly limited to the di-N-propylgroup in order to achieve selective D3 antagonists. Thus, combinations of various alkyl groupswere generally inactive at the D3 receptor. Although substitution with an N-alkylaryl orN-alkylheteroaryl group yields compounds with potent D3 binding affinity, the D2 affinity isalso enhanced, resulting in a less than 4-fold preference for the D3 receptor site, and noimprovements in metabolic stability were noted. A large-scale synthesis of the D3 antagonist3 has been developed that has proven to be reproducible with few purification steps. Theimprovements include the use of 3,4-dimethoxybenzaldehyde as a low-cost starting materialto provide the desired 5,6-dimethoxy-1-indanone 5c in good overall yield (65%) and the formationof a soluble silyl oxime 17 that was reduced efficiently with BH3·Me2S. The resulting aminoalcohol was alkylated and then deoxygenated using a Lewis acid and Et3SiH to give the desiredproduct 3 in good overall yield of (∼65%) from the indanone 5c.
|
